Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CVRX
CVRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CVRX News
CVRx Q4 2025 Earnings Call Insights
3d ago
seekingalpha
CVRx Reports Q4 Earnings Beat with Revenue Growth
3d ago
seekingalpha
CVRx Under Investigation for Possible Securities Law Violations
5d ago
Businesswire
CVRx Faces Investor Lawsuit Investigation
Jan 30 2026
Globenewswire
CVRx Under Investigation for Potential Securities Violations
Jan 30 2026
Businesswire
Pomerantz LLP Investigates CVRx for Securities Fraud
Jan 27 2026
Globenewswire
CVRx Initiates Landmark BENEFIT-HF Trial with 2,500 Patient Enrollment Target
Jan 23 2026
Benzinga
CVRx Faces Investigation After 46.3% Stock Drop Due to Salesforce Issues
Jan 13 2026
Globenewswire
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead
Nov 06 2025
NASDAQ.COM
CVRx Announces Positive News on Outpatient Payment for Barostim
Jul 16 2025
Newsfilter
CVRx to Present at the William Blair 45th Annual Growth Stock Conference
May 28 2025
Newsfilter
Monday 5/19 Insider Buying Report: HUM, CVRX
May 19 2025
NASDAQ.COM
CVRx downgraded at J.P. Morgan after Q1 sales miss
May 09 2025
SeekingAlpha
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
May 09 2025
Benzinga
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
May 09 2025
Benzinga
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
May 09 2025
Benzinga
Show More News
